Skip to main content
Premium Trial:

Request an Annual Quote

On 'Escaping the Bench'

At the PostDocs Forum, Carlton Hoyt says that "waxing lyrical about the PhD/postdoctoral system won’t change anything." As such, he discusses ways in which PhDs and postdocs might escape "the crowd by escaping the bench." In deciding whether to leave research, Hoyt says it is important first for PhDs and postdocs to assess whether they'd be successful as a scientist. "If you pragmatically look at your career and think that you have an acceptable chance at being successful as a scientist — congratulations, and more power to you," he says. "If not, it's time to formulate and execute a back-up plan." For those who realize bench research is not for them, the next step is to "align your interests and skills with other career options," Hoyt says. Finally, "while your deep scientific knowledge will almost certainly be a key asset in your future, your new career path will require new and likely undeveloped skills," he adds. Because of this, Hoyt says that after honing their interests, PhDs and postdocs must consider the skills and connections required. "Going to networking events or industry events in that area would allow you to talk to those that are already successful in that field and get their input and make useful connections," Hoyt says.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.